-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QVc3UCL4fL6vs5TANfppqrmNIaOCxJr4QQ/WWi18AvDImrKSZr+eIZZVn2Cj8795 vBBI/RDRQP1h79LY87OTGA== 0001047469-98-026943.txt : 19980714 0001047469-98-026943.hdr.sgml : 19980714 ACCESSION NUMBER: 0001047469-98-026943 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980710 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERNATIONAL MUREX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000864964 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: SEC FILE NUMBER: 000-26144 FILM NUMBER: 98664319 BUSINESS ADDRESS: STREET 1: 2255 B QUEEN STREET EAST STREET 2: SUITE 828 TORONTO CITY: ONTARIO STATE: A6 BUSINESS PHONE: 5198368016 MAIL ADDRESS: STREET 1: 2255 B QUEEN STREET EAST STREET 2: SUITE 828 TORONTO CITY: ONTARIO STATE: A6 FORMER COMPANY: FORMER CONFORMED NAME: MUREX CLINICAL TECHNOLOGIES CORP DATE OF NAME CHANGE: 19600201 15-12G 1 15-12G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934 Commission File Number 0-26144 International Murex Technologies Corporation (Exact name of registrant as specified in its charter) 3075 Northwoods Circle Norcross, Georgia 30071-1542 (770) 662-0660 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Shares, No Par Value (Title of each class of securities covered by this Form) Not applicable (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ] Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ] Rule 12h-3(b)(1)(i) [ ] Approximate number of holders of record as of the certification or notice date: 2 Pursuant to the requirements of the Securities Exchange Act of 1934, International Murex Technologies Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. INTERNATIONAL MUREX TECHNOLOGIES CORPORATION DATE: July 10, 1998 By: /s/ Thomas D. Brown ----------------------------- Name: Thomas D. Brown Title: Vice President -----END PRIVACY-ENHANCED MESSAGE-----